A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin
- PMID: 33011805
- DOI: 10.1093/cid/ciaa1506
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin
Comment in
-
Reply to Agrawal and Kumar.Clin Infect Dis. 2021 Aug 2;73(3):e846. doi: 10.1093/cid/ciaa1507. Clin Infect Dis. 2021. PMID: 33011769 No abstract available.
Comment on
-
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).Clin Infect Dis. 2021 Nov 2;73(9):e2722-e2728. doi: 10.1093/cid/ciaa779. Clin Infect Dis. 2021. PMID: 32556113 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
